Petros Paul Sfikakis

This study creates a multi-organ single-cell atlas of systemic sclerosis to identify shared and tissue-specific transcriptional programs and potential therapeutic targets.

This study identifies an m6A epitranscriptomic signature in systemic sclerosis that drives profibrotic changes, which can be reversed by METTL3 inhibition.

This study examines Stab1 and Stab2 levels and their ligands in T2DM patients to assess their relationship with atherosclerotic plaque burden and lipid metabolism.

This study shows exercise induces anti-inflammatory reprogramming in macrophages via Hsp60, identified through secretome analysis and proteomic profiling.